Related references
Note: Only part of the references are listed.Triple Artemisinin-Based Combination Therapies for Malaria - A New Paradigm?
Rob W. van der Pluijm et al.
TRENDS IN PARASITOLOGY (2021)
Efficacy and safety of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria and prevalence of molecular markers associated with artemisinin and partner drug resistance in Uganda
Chris Ebong et al.
MALARIA JOURNAL (2021)
Association of Plasmodium falciparum kelch13 R561H genotypes with delayed parasite clearance in Rwanda: an open-label, single-arm, multicentre, therapeutic efficacy study
Aline Uwimana et al.
LANCET INFECTIOUS DISEASES (2021)
Targeting Gametocytes of the Malaria Parasite Plasmodium falciparum in a Functional Genomics Era: Next Steps
Jyotsna Chawla et al.
PATHOGENS (2021)
Evidence of Artemisinin-Resistant Malaria in Africa
Betty Balikagala et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Plasmodium interspecies interactions during a period of increasing prevalence of Plasmodium ovale in symptomatic individuals seeking treatment: an observational study
Hoseah M. Akala et al.
LANCET MICROBE (2021)
Continued Low Efficacy of Artemether-Lumefantrine in Angola in 2019
Pedro Rafael Dimbu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2021)
Recovery and stable persistence of chloroquine sensitivity in Plasmodium falciparum parasites after its discontinued use in Northern Uganda
Betty Balikagala et al.
MALARIA JOURNAL (2020)
Development of copy number assays for detection and surveillance of piperaquine resistance associated plasmepsin 2/3 copy number variation in Plasmodium falciparum
Megan R. Ansbro et al.
MALARIA JOURNAL (2020)
Piperaquine resistant CambodianPlasmodium falciparumclinical isolates: in vitro genotypic and phenotypic characterization
Nonlawat Boonyalai et al.
MALARIA JOURNAL (2020)
Assessment of molecular markers of anti-malarial drug resistance among children participating in a therapeutic efficacy study in western Kenya
Winnie Chebore et al.
MALARIA JOURNAL (2020)
Effect of mass dihydroartemisinin-piperaquine administration in southern Mozambique on the carriage of molecular markers of antimalarial resistance
Himanshu Gupta et al.
PLOS ONE (2020)
The past, present and future of anti-malarial medicines
Edwin G. Tse et al.
MALARIA JOURNAL (2019)
African isolates show a high proportion of multiple copies of the Plasmodium falciparum plasmepsin-2 gene, a piperaquine resistance marker
Didier Leroy et al.
MALARIA JOURNAL (2019)
Declining responsiveness of childhood Plasmodium falciparum infections to artemisinin-based combination treatments ten years following deployment as first-line antimalarials in Nigeria
Akintunde Sowunmi et al.
INFECTIOUS DISEASES OF POVERTY (2019)
A comprehensive analysis of drug resistance molecular markers and Plasmodium falciparum genetic diversity in two malaria endemic sites in Mali
Seidina A. S. Diakite et al.
MALARIA JOURNAL (2019)
Therapeutic failure after regimen with artemether-lumefantrine combination therapy: a report of three cases in Benin City, Nigeria
Osamudiamen Ebohon et al.
REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL (2019)
Efficacy of artemisinin-based combination therapies and prevalence of molecular markers associated with artemisinin, piperaquine and sulfadoxine-pyrimethamine resistance in Sierra Leone
Samuel J. Smith et al.
ACTA TROPICA (2018)
Drugs in Development for Malaria
Elizabeth A. Ashley et al.
DRUGS (2018)
Tools for surveillance of anti-malarial drug resistance: an assessment of the current landscape
Christian Nsanzabana et al.
MALARIA JOURNAL (2018)
Absence of a High Level of Duplication of the Plasmepsin Gene in Africa
Marie Gladys Robert et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Mechanisms of resistance to the partner drugs of artemisinin in the malaria parasite
Rowena E. Martin et al.
CURRENT OPINION IN PHARMACOLOGY (2018)
Plasmodium falciparum Plasmepsin 2 Duplications, West Africa
Juliana Inoue et al.
EMERGING INFECTIOUS DISEASES (2018)
Genetic markers associated with dihydroartemisinin-piperaquine failure in Plasmodium falciparum malaria in Cambodia: a genotype-phenotype association study
Roberto Amato et al.
LANCET INFECTIOUS DISEASES (2017)
The malaria testing and treatment landscape in Kenya: results from a nationally representative survey among the public and private sector in 2016
Anne Musuva et al.
MALARIA JOURNAL (2017)
Return of chloroquine sensitivity to Africa? Surveillance of African Plasmodium falciparum chloroquine resistance through malaria imported to China
Feng Lu et al.
PARASITES & VECTORS (2017)
Influence of the pfmdr1 Gene on In Vitro Sensitivities of Piperaquine in Thai Isolates of Plasmodium falciparum
Mathirut Mungthin et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2017)
Changing Antimalarial Drug Sensitivities in Uganda
Stephanie A. Rasmussen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Molecular Profile of Malaria Drug Resistance Markers of Plasmodium falciparum in Suriname
Stella M. Chenet et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Assessment of the Worldwide Antimalarial Resistance Network Standardized Procedure for In Vitro Malaria Drug Sensitivity Testing Using SYBR Green Assay for Field Samples with Various Initial Parasitemia Levels
Agnes C. Cheruiyot et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Plasmodium falciparum dihydroartemisinin-piperaquine failures in Cambodia are associated with mutant K13 parasites presenting high survival rates in novel piperaquine in vitro assays: retrospective and prospective investigations
Valentine Duru et al.
BMC MEDICINE (2015)
Analysis of Major Genome Loci Underlying Artemisinin Resistance and pfmdr1 Copy Number in pre- and post-ACTs in Western Kenya
Bidii S. Ngalah et al.
SCIENTIFIC REPORTS (2015)
Temporal trends in prevalence of Plasmodium falciparum molecular markers selected for by artemether-lumefantrine treatment in pre-ACT and post-ACT parasites in western Kenya
Angela O. Achieng et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY-DRUGS AND DRUG RESISTANCE (2015)
Efficacy and safety of artemether-lumefantrine and dihydroartemisinin-piperaquine in the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children aged less than five years: results of an open-label, randomized, single-centre study
Bernhards R. Ogutu et al.
MALARIA JOURNAL (2014)
Temporal trends in prevalence of Plasmodium falciparum drug resistance alleles over two decades of changing antimalarial policy in coastal Kenya
John Okombo et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY-DRUGS AND DRUG RESISTANCE (2014)
In Vitro Sensitivities of Plasmodium falciparum Isolates from the China-Myanmar Border to Piperaquine and Association with Polymorphisms in Candidate Genes
Mingming Hao et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
In vitro piperaquine susceptibility is not associated with the Plasmodium falciparum chloroquine resistance transporter gene
Aurelie Pascual et al.
MALARIA JOURNAL (2013)
Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy
Nancy O. Duah et al.
MALARIA JOURNAL (2013)
The Role of Pfmdr1 and Pfcrt in Changing Chloroquine, Amodiaquine, Mefloquine and Lumefantrine Susceptibility in Western-Kenya P. falciparum Samples during 2008-2011
Fredrick L. Eyase et al.
PLOS ONE (2013)
Antimalarial Drug Sensitivity Profile of Western Kenya Plasmodium falciparum Field Isolates Determined by a SYBR Green I in vitro Assay and Molecular Analysis
Hoseah M. Akala et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2011)
Randomized trials of artemisinin-piperaquine, dihydroartemisinin-piperaquine phosphate and artemether-lumefantrine for the treatment of multi-drug resistant falciparum malaria in Cambodia-Thailand border area
Jianping Song et al.
MALARIA JOURNAL (2011)
Implementation of a reference standard and proficiency testing programme by the World Wide Antimalarial Resistance Network (WWARN)
Chris Lourens et al.
MALARIA JOURNAL (2010)
In Vitro Activities of Piperaquine, Lumefantrine, and Dihydroartemisinin in Kenyan Plasmodium falciparum Isolates and Polymorphisms in pfcrt and pfmdr1
Leah Mwai et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Spread and evolution of Plasmodium falciparum drug resistance
Toshihiro Mita et al.
PARASITOLOGY INTERNATIONAL (2009)
Effectiveness of quinine versus artemether-lumefantrine for treating uncomplicated falciparum malaria in Ugandan children: randomised trial
Jane Achan et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
Efficacy of artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in northwest Cambodia
Mey Bouth Denis et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2006)
Geographic differences in antimalarial drug efficacy in Uganda are explained by differences in endemicity and not by known molecular markers of drug resistance
D Francis et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
In vitro activities of piperaquine and other 4-aminoquinolines against clinical isolates of Plasmodium falciparum in Cameroon
LK Basco et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Share Paper
